Skip to main content

Table 5 Cardiovascular measures in T2DM patients according to HbA1c levels

From: Impact of glycemic control on aortic stiffness, left ventricular mass and diastolic longitudinal function in type 2 diabetes mellitus

  HbA1c <6.5% HbA1c ≥6.5% P
N 40 85  
Age (years) 58 ± 8 58 ± 10 0.74
Male:female 25:15 60:25 0.37
T2DM duration (years) 6.0 ± 5.2 7.6 ± 6.8 0.18
HbAc1 (%) 6.1 ± 0.3 7.6 ± 0.9 <0.0001
Carotid systolic BP (mmHg) 119 ± 13 126 ± 14 0.01
cfPWV (m/s) 8.0 ± 1.5 8.7 ± 1.9 <0.05
Increased cfPWV (%) 15.0 32.9 <0.05
ccaPWV (m/s) 8.3 ± 1.6 8.5 ± 1.8 0.31
LVMI (g/m2.7) 46 ± 10 52 ± 10 0.005
LVH (%) 35.0 58.8 0.01
e′ velocity (cm/s) 10.1 ± 1.6 9.1 ± 1.7 0.001
Diastolic dysfunction (%) 22.5 40.0 <0.05
s′ velocity (cm/s) 9.5 ± 1.5 8.9 ± 1.4 <0.05
ess-MWS (%) 105 ± 13 99 ± 16 <0.05